Donald J Griffith's most recent trade in Sonnet BioTherapeutics Holdings Inc was a trade of 10,000 Common Stock done . Disclosure was reported to the exchange on July 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sonnet BioTherapeutics Hol... | Donald J. Griffith | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 10,000 | 10,375 | - | - | Common Stock | |
| Sonnet BioTherapeutics Hol... | Donald J. Griffith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2023 | 317 | 375 | - | - | Common Stock | |
| Sonnet BioTherapeutics Hol... | Donald J. Griffith | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.51 per share. | 25 May 2021 | 4,235 | 95,693 | - | 1.5 | 6,395 | Common Stock |